Seraph Biosciences, Inc., founded in 2014 and headquartered in Detroit, Michigan, is a biomedical device company focused on revolutionizing diagnostic technology. Their core mission is to provide real-time pathogen detection at the point of care using their innovative Seraspec® technology. By leveraging Raman Spectroscopy, Seraspec® offers a portable solution for the rapid screening and identification of bacterial, viral, and fungal pathogens, eliminating the need for traditional, time-consuming laboratory methods.
Notable affiliates and investors include key figures from the biomedical and tech industries who have supported the development and commercialization of Seraspec®. The company has achieved significant milestones, including securing patents for their technology and gaining recognition for their contributions to point-of-care diagnostics. Seraph Biosciences' impact lies in its potential to transform pathogen detection, making it faster, more efficient, and accessible, thereby improving patient outcomes and healthcare efficiency.
